Skip to main content
SpringerLink
Log in

Substance P—An underlying factor for pouchitis?

Prospective study of substance P- and vasoactive intestinal polypeptide-immunoreactive innervation and mast cells

  • Intestinal Disorders, Inflammatory Bowel Disease, Immunology, And Microbiology
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Recent studies suggest that substance P (SP), vasoactive intestinal polypeptide (VIP), and mast cells play a role in inflammatory processes of the bowel. The aim of this study was to evaluate the distribution of SP and VIP immunoreactivities and to count mast cells in the ileal pouch of patients, who had pouchitis after restorative proctocolectomy performed for treatment of ulcerative colitis (UC), and to compare the findings in the same patients after a follow-up period. Nine patients with pouchitis underwent clinical evaluation, endoscopy of the pouch, and histological examination, which were repeated after the follow-up period of 14 months on average. The number and intensity of SP- and VIP-immunoreactive nerve fibers were visualized by immunofluorescence microscopy and subjected to quantitative scoring, and the number of mast cells per unit area was counted. The results were compared to the histological findings and the clinical status. Lamina propria contained fibers showing bright immunofluorescence for SP and VIP. The mean fluorescence intensity score of SP-immunoreactive nerve fibers in the lamina propria remained similar after the follow-up period (2.99±0.79 and 2.06±0.82, NS). SP-immunoreactive innervation correlated with the grade of acute (R 2=0.5396,P=0.0242) and chronic inflammation (R 2=0.4561,P=0.0459), while SP and VIP immunoreactivity, mast cell count, and histological changes did not correlate with the clinical status. The present study demonstrates an increase in the density of SP-immunoreactive nerve fibers in inflamed ileal pouch mucosa of clinically asymptomatic pouchitis patients. These results raise the possibility of therapeutic interference of SP-related processes in treatment of pouchitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goldman H: Acute versus chronic colitis: How and when to distinguish by biopsy. Gastroenterology 86:199–201, 1984

    PubMed  Google Scholar 

  2. Moskowitz RL, Shepherd NA, Nicholls RJ: An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorect Dis 1:167–174, 1986

    Google Scholar 

  3. Kmiot WA, Hesslewood SR, Smith N, Thompson H, Harding LK, Keighley MR: Evaluation of the inflammatory infiltrate in pouchitis with111In-labeled granulocytes. Gastroenterology 104:981–988, 1993

    PubMed  Google Scholar 

  4. de Silva HJ, Millard PR, Kettlewell M, Mortensen NJ, Prince C, Jewell DP: Mucosal characteristics of pelvic ileal pouches. Gut 32:61–65, 1991

    PubMed  Google Scholar 

  5. Carraro P, Talbot I, Nicholls R: Longterm appraisal of the histological appearances of the ileal reservoir mucosa after restorative proctocolectomy for ulcerative colitis. Gut 35:1721–1727, 1994

    PubMed  Google Scholar 

  6. Madden MV, Farthing MJG, Nicholls RJ: Inflammation in ileal reservoirs: Pouchitis. Gut 31:247–249, 1990

    PubMed  Google Scholar 

  7. Mantyh C, Gates T, Zimmerman R, Welton M, Passaro E, Vigna S, Maggio J, Kruger L, Mantyh P: Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn's disease. Proc Natl Acad Sci USA 85:3235–3239, 1988

    PubMed  Google Scholar 

  8. Scott AD, Phillips RKS: Ileitis and pouchitis after colectomy for ulcerative colitis. Br J Surg 76:668–669, 1989

    PubMed  Google Scholar 

  9. Shepherd NA, Healey CJ, Warren BF, Richman PI, Thomson WH, Wilkinson SP: Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut 34:101–105, 1993

    PubMed  Google Scholar 

  10. Luukkonen P, Järvinen H, Tanskanen M, Kahri A: Pouchitis—recurrence of the inflammatory bowel disease? Gut 35:243–246, 1994

    PubMed  Google Scholar 

  11. Banerjee A: Hypothesis—pouchitis represents a useful clinical model of ulcerative colitis. Med Hypotheses 42:36–38, 1994

    PubMed  Google Scholar 

  12. Llewellyn-Smith I, Furness J, Murphy R, O'Brien P, Costa M: Substance P-containing nerves in the human small intestine. Gastroenterology 86:421–435, 1984

    PubMed  Google Scholar 

  13. Elson C, Kagnoff M, Fiocchi C, Befus A, Targan S: Intestinal immunity and inflammation: Recent progress. Gastroenterology 91:746–768, 1986

    PubMed  Google Scholar 

  14. Mantyh P, Catton M, Maggio J, Vigna S: Alterations in receptors for sensory neuropeptides in human inflammatory bowel disease.In Sensory nerves and neuropeptides in gastroenterology. M Costa (ed). New York, Plenum Press, 1991, p 253

    Google Scholar 

  15. Shanahan F, Anton P: Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease. Dig Dis Sci 33:41–49, 1988

    PubMed  Google Scholar 

  16. Koch T, Carney A, Co V: Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 32:369–376, 1987

    PubMed  Google Scholar 

  17. Goldin E, Karmeli F, Selinger Z, Rachmilewitz D: Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 34:754–757, 1989

    PubMed  Google Scholar 

  18. Keränen U, Kiviluoto T, Järvinen H, Bäck N, Kivilaakso E, Soinila S: Changes in the substance P-immunoreactive innervation of the human colon associated with ulcerative colitis. Dig Dis Sci 40:2250–2258, 1995

    PubMed  Google Scholar 

  19. Ferri G, Botti P, Vazzadini P, Biliotti G, Bloom S, Polak J: Peptide-containing innervation of the human intestinal mucosa. Histochemistry 76:413–420, 1982

    PubMed  Google Scholar 

  20. Ferri G, Adrian T, Ghatei M, O'Shaughnessy D, Probert L, Lee Y, Buchan A, Polak J, Bloom S: Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology 84:777–786, 1983

    PubMed  Google Scholar 

  21. Keränen U, Järvinen H, Kiviluoto T, Kivilaakso E, Soinila S: Substance P- and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis. Dig Dis Sci 41:1658–1664, 1996

    PubMed  Google Scholar 

  22. Grider JR, Jin JG: Vasoactive intestinal peptide release andl-citrulline production from isolated ganglia of the myenteric plexus: Evidence for regulation of vasoactive intestinal peptide release by nitric oxide. Neuroscience 54:521–526, 1993

    PubMed  Google Scholar 

  23. Grider JR: Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis. Am J Physiol 264:G334-G340, 1993

    PubMed  Google Scholar 

  24. Polak JM, Bodian C: The neuroendocrine design of the gut. J Clin Endocrinol Metab 8:313, 1979

    Google Scholar 

  25. Makhlouf GM, Said SI: The effect of vasoactive intestinal polypeptide (VIP) on digestive and hormonal function.In Gastrointestinal hormones, JC Thompson (ed), Austin, University of Texas Press, 1975, p 599

    Google Scholar 

  26. Greenberg GR, Buchan AMJ, McLeod RS, Preston P, Cohen Z: Gut hormone responses after reconstructive surgery for ulcerative colitis. Gut 30:1721–1730, 1989

    PubMed  Google Scholar 

  27. Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S: Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology 79:853–860, 1980

    PubMed  Google Scholar 

  28. Bercovitz ZT, Sommers SC: Altered inflammatory reaction in nonspecific ulcerative colitis. Arch Intern Med 117:504–510, 1966

    PubMed  Google Scholar 

  29. King T, Biddle W, Bhatia P, Moore J, Miner PBJ: Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig Dis Sci 37:490–495, 1992

    PubMed  Google Scholar 

  30. Fox CC, Moore WC, Lichtenstein LM: Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci 36:179–184, 1991

    PubMed  Google Scholar 

  31. Fox CC, Lazenby AJ, Moore WC, Yardley JH, Bayless TM, Lichtenstein LM: Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 99:119–124, 1990

    PubMed  Google Scholar 

  32. Fox CC, Lichtenstein LM, Roche JK: Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins. Dig Dis Sci 38:1105–1112, 1993

    PubMed  Google Scholar 

  33. Nolte H, Spjeldnaes N, Kruse A, Windelborg B: Histamine release from gut mast cells from patients with inflammatory bowel diseases. Gut 31:791–794, 1990

    PubMed  Google Scholar 

  34. Dvorak AM, McLeod RS, Ordendonk A, Monahan-Earley RA, Cullen JB, Antonioli DA, Morgan E, Blair JE, Estrella P, Cisneros RL, Silen W, Cohen Z: Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cellsin vivo. Int Arch Allergy Immunol 99(1):74–83, 1992

    PubMed  Google Scholar 

  35. Stead RH, Dixon MF, Bramwell NH, Riddel RH, Bienenstock J: Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97:575–585, 1989

    PubMed  Google Scholar 

  36. Crivellato E, Damiani D, Mallardi F, Travan L: Suggestive evidence for a microanatomical relationship between mast cells and nerve fibres containing substance P, calcitonin gene related peptide, vasoactive intestinal polypeptide, and somatostatin in the rat mesentery. Acta Anat 141:127–131, 1991

    PubMed  Google Scholar 

  37. Dvorak AM, McLeod RS, Onderdonk AB, Monahan Earley RA, Cullen JB, Antonioli DA, Morgan E, Blair JE, Estrella P, Cisneros RL, Cohen Z, Silen W: Human gut mucosal mast cells: Ultrastructural observations and anatomic variation in mast cell-nerve associationsin vivo. Int Arch Allergy Immunol 98:158–168, 1992

    PubMed  Google Scholar 

  38. Perdue MH, Marshall J, Masson S: Ion transport abnormalities in inflamed rat jejunum. Involvement of mast cells and nerves. Gastroenterology 98:561–567, 1990

    PubMed  Google Scholar 

  39. MacQueen G, Marshall J, Perdue MH, Siegel S, Bienenstock J: Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 243:83–85, 1989

    PubMed  Google Scholar 

  40. McCafferty DM, Sharkey KA, Wallace JL: Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol 266:G560-G567, 1994

    PubMed  Google Scholar 

  41. Mazumdar S, Das K: Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. Gastroenterology 87:176–181, 1992

    Google Scholar 

  42. McLeod RS, Antonioli D, Cullen J, Dvorak A, Onderdonk A, Silen W, Blair JE, Monahan Earley R, Cisneros R, Cohen Z: Histologic and microbiologic features of biopsy samples from patients with normal and inflamed pouches. Dis Colon Rectum 37:26–31, 1994

    PubMed  Google Scholar 

  43. Shepherd NA: The pelvic ileal reservoir: Pathology and pouchitis. Neth J Med 37 (suppl 1):S57-S64, 1990

    PubMed  Google Scholar 

  44. Kmiot WA, Youngs D, Tudor R, Thompson H, Keighley MR: Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis. Br J Surg 80:1445–1449, 1993

    PubMed  Google Scholar 

  45. Sandborn W, Tremaine W, Batts K, Pemberton J, Phillips S: Pouchitis after ileal pouch-anal anastomosis: A pouchitis disease activity index. Mayo Clin Proc 69:409–415, 1994

    PubMed  Google Scholar 

  46. Shepherd NA, Jass JR, Duval I, Moskowitz RL, Nicholls RJ, Morson BC: Restorative proctocolectomy with ileal reservoir—the histopathology of mucosal biopsies. J Clin Pathol 40:601–607, 1987

    PubMed  Google Scholar 

  47. Bartho L, Holzer P: Search for a physiological role of substance P in gastrointestinal motility. Neuroscience 16:1–32, 1985

    PubMed  Google Scholar 

  48. Björck S, Dahlström A, Johansson L, Ahlman H: Treatment of the mucosa with local anaeshetics in ulcerative colitis. Agents Actions 35(suppl):C60-C72, 1992

    Google Scholar 

  49. McCafferty D-M, Sharkey KA, Wallace JL: Beneficial effect of local or systemic lidocaine in experimental colitis. Am J Physiol 266:G560-G567, 1994

    PubMed  Google Scholar 

  50. Mortensen N: Restorative proctocolectomy—the pouch operation: Good or bad? Scand J Gastroenterol Suppl 192:130–135, 1992

    PubMed  Google Scholar 

  51. Fozard BJ, Pemberton JH: Results of pouch surgery after ileo-anal anastomosis: The implications of pouchitis. World J Surg 16:880–884, 1992

    PubMed  Google Scholar 

  52. Salemans JM, Nagengast FM, Lubbers EJ, Kuijpers JH: Post-operative and long-term results of ileal pouch-anal anastomosis for ulcerative colitis and familial polyposis coli Dig Dis Sci 37:1882–1889, 1992

    Google Scholar 

  53. Marcello PW, Roberts PL, Schoetz DJ Jr, Coller JA, Murray JJ, Veidenheimer MC: Long-term results of the ileoanal pouch procedure. Arch Surg 128:500–503, 1993

    PubMed  Google Scholar 

  54. Järvinen HJ, Luukkonen P: Experience with restorative proctocolectomy in 201 patients. Ann Chir Gynaecol 82:159–164, 1993

    PubMed  Google Scholar 

  55. McIntyre PB, Pemberton JH, Wolff BG, Beart RW, Dozois RR: Comparing functional results one year and ten years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Dis Colon Rectum 37:303–307, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Helsinki, Finland

    Ulla Keränen MD, Heikki Järvinen MD, Päivi Kärkkäinen MD, Tuula Kiviluoto MD, Eero Kivilaakso MD & Seppo Soinila MD

  2. Institute of Biomedicine, Department of Anatomy and Neurology, University of Helsinki, Finland

    Ulla Keränen MD, Heikki Järvinen MD, Päivi Kärkkäinen MD, Tuula Kiviluoto MD, Eero Kivilaakso MD & Seppo Soinila MD

  3. II Department of Surgery, Helsinki University Central Hospital, Haartmaninkatu 4, 00290, Helsinki, Finland

    Ulla Keränen MD, Heikki Järvinen MD, Päivi Kärkkäinen MD, Tuula Kiviluoto MD, Eero Kivilaakso MD & Seppo Soinila MD

Authors
  1. Ulla Keränen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heikki Järvinen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Päivi Kärkkäinen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tuula Kiviluoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eero Kivilaakso MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seppo Soinila MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study has been supported financially by grants from Sigrid Juselius Foundation, Medical Research Council of the Academy of Finland and Foundation of Gastroenterological Diseases, Helsinki, Finland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keränen, U., Järvinen, H., Kärkkäinen, P. et al. Substance P—An underlying factor for pouchitis?. Digest Dis Sci 41, 1665–1671 (1996). https://doi.org/10.1007/BF02087922

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087922

Key words

Search

Navigation